HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer by Jian Yang et al.
RESEARCH Open Access
HIF-2α promotes epithelial-mesenchymal
transition through regulating Twist2
binding to the promoter of E-cadherin in
pancreatic cancer
Jian Yang1†, Xu Zhang1†, Yi Zhang1†, Dongming Zhu1, Lifeng Zhang1, Ye Li1, Yanbo Zhu2, Dechun Li1
and Jian Zhou1*
Abstract
Background: Epithelial-mesenchymal transition (EMT) is a dedifferentiation process that mainly involves in
mesenchymal marker upregulation, epithelial maker downregulation and cell polarity loss. Related hypoxia factors
play a crucial role in EMT, however, it remains few evidence to clarify the role of HIF-2α in EMT in pancreatic cancer.
Method: In this study, we investigated the expression of HIF-2α and E-cadherin by immunohistochemistry in 70
pancreatic cancer patients, as well as the correlation to the clinicopathologic characteristics. Then we regulated the
expression of HIF-2α in pancreatic cancer cells to examine the role of HIF-2α on invasion and migration in vitro.
Finally, we tested the relation of HIF-2α and EMT related proteins by Western blot and determined whether HIF-2α
regulated EMT through Twist regulating the expression of E-cadherin by Chromatin immunoprecipitation (ChIP)
assay.
Results: We found that HIF-2α protein was expressed positively in 67.1 % (47/70) of pancreatic cancer tissues and
11.4 % (8/70) of adjacent non-tumor pancreatic tissues, and there was a significant difference in the positive rate of
HIF-2α protein between two groups (χ2 = 45.549, P < 0.05). In addition, the staining for HIF-2α was correlated with
tumor differentiation (P < 0.05), clinical stage (P < 0.05) and lymph node metastasis (P < 0.05), while E-cadherin
expression was only correlated with lymph node metastasis (P < 0.05). HIF-2α promoted cell migration, invasion in
vitro, and regulated the expression of E-cadherin and MMPs, which are critical to EMT. Our further ChIP assay
suggested that only Twist2 could bind to the promoter of E-cadherin in -714 bp region site, but there is no positive
binding capacity in -295 bp promoter region site of E-cadherin. Clinical tissues IHC staining showed that Twist2 and
E-cadherin expression had an obviously negative correlation in pancreatic cancer. Nevertheless, it had no obvious
correlation between Twist1 and E-cadherin.
Conclusion: These findings indicated that HIF-2α promotes EMT in pancreatic cancer by regulating Twist2 binding
to the promoter of E-cadherin, which meant that HIF-2α and this pathway may be effective therapeutic targets for
pancreatic cancer.
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Background
Pancreatic cancer is a solid malignancy which is gener-
ally characterized by a poor prognosis. The radical resec-
tion of pancreatic tumors, especially in the stage of
precursor lesions, may be the only hope for cure [1].
However, even after surgical resection, the 5-year sur-
vival is only 20 % due to its high recurrence rate [2], in
addition, radiotherapy and chemotherapy obtain little
benefit [3]. Vascular invasion and distant metastasis are
the critical features in the aggressive phenotype of pan-
creatic cancer.
As solid tumors growing, their microenviromental
condition becomes gradually hypoxic. Under condi-
tions of hypoxia, a signaling pathway involving a cru-
cial oxygen response regulator, defined hypoxia-
inducible factor (HIF), is turned on [4]. Misregulation
of HIF protein, especially HIF-1α and HIF-2α, is cor-
relation with tumor development and metastasis [5].
Substantial experiments were carried out to determine
the role and mechanism of HIF-1α in various tumors.
In contrast with HIF-1α, which is expressed in most
metazoan species, the expression of HIF-2α is ob-
served in certain cell types of vertebrate species [6].
Indeed, HIF-2α has been proved to play an important
role in many aspects of digestive cancers, containing
proliferation, angiogenesis metabolism, metastasis and
resistance to chemotherapy [7].
Epithelial-mesenchymal transition (EMT) is a dediffer-
entiation process, which plays an integral role in tumor
progression [8]. In the process of EMT, cells acquired
mesenchymal characteristics and lost epithelial pheno-
types, mainly involved in mesenchymal marker upregu-
lation, epithelial maker downregulation and cell polarity
loss [8, 9]. Loss of E-cadherin plays a key role in the
EMT differentiation process and leads to increase cellu-
lar motility and invasion. As a main EMT-mediated
transcription factor, twist reportedly contributes to cad-
herin switching. Interestingly, twist is a member of the
basic helix-loop-helix (bHLH) transcription factor family
and structural similarity with HIF at the bHLH [10, 11].
The function of HIF and Twist may have some similar-
ity. Research has been demonstrated that Twist is corre-
lated with metastasis of multiple malignant tumors of
epithelial origin [12] and involves in the regulation of
EMT [10, 13].
Related hypoxia factors play a crucial role in EMT
[14], however, there is little evidence to clarify the
role of HIF-2α in EMT in pancreatic cancer. In this
study, we examined the expression of HIF-2α and E-
cadherin in pancreatic cancer, as well as the correl-
ation to the clinicopathologic characteristics. Then
we investigated the role of HIF-2α in EMT process
in pancreatic cancer cells. Finally, we tested the rela-
tion of HIF-2α and EMT related proteins and
determined whether HIF-2α regulated EMT through
Twist regulating the expression of E-cadherin.
Methods
Clinical samples
Tumor tissues of 70 patients were obtained from the
First Affiliated Hospital of Soochow University from
2011 to 2013. Formalin-fixed tumor tissues were used
for immunohistochemistry (IHC), including tumor sam-
ples and matching adjacent non-tumor tissues. Detailed
clinicopathological data were recorded, including each
patient’s age, gender, tumor size, tumor differentiation,
and lymph node metastasis, and tumor clinical stages
were classified according to the UICC staging system.
None of the patients received chemotherapy, radiother-
apy or immunotherapy before surgery. All the samples
were obtained following patient consent and approval by
the Ethics Committee of Soochow University.
Expression plasmids and HIF-2α gene silencing
Full-length HIF-2α complementary DNA (cDNA) was
amplified by normal human embryo cDNA, digested with
XhoI/EcoRIand subcloned into pcDNA3.1 vectors (OE-
HIF-2α). The empty pcDNA3.1 vectors served as a nega-
tive control (Vector). The small interfering RNA (siRNA)
was constructed by GeneChem Co., Ltd. (Shanghai,
China). The siRNA sequence targeting HIF-2α (si-HIF-2α)
was 5′-GCAAATGTACCCAATGATA-3′, as confirmed
by sequencing. A nonspecific scrambled siRNA sequence
(si-Scramble) was used as a negative control (target se-
quence 5′- GTTCTCCGAACGTGTCACGT-3′).
Cell culture and transfection
The pancreatic cancer cell lines of AsPC-1, CaPan-2,
PaTu8988, SW1990, BXPC-3 were obtained from the
Chinese Academy of Sciences (Shanghai, China). The
cells were maintained with DMEM (HyClone, Shanghai,
China) supplemented with 10 % fetal bovine serum
(FBS, HyClone, Shanghai, China) and cultured at 37 °C
in a humidified atmosphere containing 5 % CO2.
SW1990 and AsPC-1 cell expressing OE-HIF-2α or si-
HIF-2α were performed by Lipofectamine 2000 (Invitro-
gen, CA, USA).
Western blot
Cells were collected and lysed in lysis buffer on ice.
Total proteins were separated by 10 % SDS-PAGE and
blotted on PVDF membrane. Membranes were blocked
with 10 % non-fat milk powder at room temperature for
2 h and incubated with primary antibodies: anti-HIF2α
(1:200), anti-VE-cadherin (1:1000), anti-MMP2 (1:1000),
anti-MMP9 (1:5000), anti-Twist1 (1:200), anti-Twist2
(1:50) (all from Abcam, Cambridge, UK) and anti-
GAPDH (1:1000, Santa Cruz Biotechnology, CA, USA),
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at 4C overnight. After three washes, the membranes
were incubated with a horseradish peroxidase-
conjugated goat anti-mouse IgG (1:2000; Santa Cruz
Biotechnology). Reactive bands were detected using
ECL western blotting detection reagent (GE Health-
care, USA).
Wound healing assay
Cells from each group were incubated in 6-well plates. A
small wound area was made in the confluent monolayer
with a 200 μl pipette tip in a lengthwise stripe. The cells
were washed twice with PBS and incubated at 37C. The
speed of wound closure was monitored after 24 and
48 h by measuring the ratio of the distance of the wound
at 0 h. Wound width was measured at 100× magnifiation
using a microscope (Leica Microsystems, Mannheim,
Germany). Each experiment was performed in triplicate.
Cell invasion assay
Cell invasion was performed in Transwell cell culture
chambers with 8 μm pores (Corning, NY,USA). The in-
serts in the membrane filter were coated with Matrigel
on the upper surface. Cells at concentration of 5 × 105/
ml resuspended in serum-free DMEM were placed on
the upper chamber, while the lower chamber was filled
with DMEM with 10%FBS. After incubation at 37 °C for
48 h, the cells on the upper surface of the filter were re-
moved with a cotton swab. Invading cells at the bottom
of Matrigel were fixed in methanol and stained with
0.1 % crystal violet. The number of invading cells was
counted under a microscope at 200 ×magnification of 5
random fields per well. Each experiment was performed
in triplicate.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assay was per-
formed using a ChIP assay kit (Upstate Biotechnology,
LP, USA) as described by the manufacturer. AsPC-1 cells
were lysed, and the immunoprecipitation was performed
with anti-Twist1 polyclonal antibody (Santa Cruz Bio-
technology, CA, USA), anti-Twist2 monoclonal antibody
(Abcam, Cambridge, UK) or mouse immunoglobulin G
(IgG; negative control). Following the wash, the
antibody-protein-DNA complex was eluted from the
beads and reversed cross-link incubation. After removed
protein and RNA, purified DNA was subjected to poly-
merase chain reaction (PCR) with primers specific for hu-
man E-cadehrin promoter. The primers for PCR were as
follows: P1: F: 5′- GAACCCAAGAGGCGAAGG-3′ and
R: 5′-GGTGCTGGACATTGAAGATTACT − 3′(154 bp);
P2: F: 5′-GCCAGGATGGTCTCAATCTC-3′ and R: 5′-
CTCCCTATGCTGTTGTGGG-3′(194 bp).
Immunohistochemistry (IHC)
Serial sections (4 μm) subjected to immunohistologi-
cal staining were fixed with freshly prepared
3 % H2O2 with 0.1 % sodium azide to quench en-
dogenous peroxidase and then treated with antigen
retrieval solution for 15 min. After placing in block-
ing reagent for 15 min, the sections were incubated
in primary anti-HFI-2α (1:500, Abcam), anti-E-
cadherin (1:1000, Abcam), anti-Twist1 (1:500, Abcam)
and anti-Twist2 (1:350, Abcam) monoclonal antibody
overnight at 4 °C, followed by incubation with the
secondary antibody and Extravidin-conjugated horse-
radish peroxidase. The staining intensity was scored
as: 0 (<10 %), 1 (10–50 %), 2 (>50 %). The final score
was calculated by multiplication of the intensity score
the quantity score. A score ≥ 2 was considered to rep-
resent positive expression.
Statistical analysis
All data in the study were evaluated with SPSS version
18.0 software. Data were presented as mean ± SD. Con-
tinuous variables were compared one-way analysis of
variance (oneway ANOVA) and categorical variable were
compared by Chi-square test. Correlation analysis was
performed using Spearman analysis. Difference was con-
sidered significant at values of P < 0.05.
Results
Expression of HIF-2α and E-cadherin in pancreatic cancer
To investigate the roles of HIF-2α and E-cadherin in
the progression of pancreatic cancer, we firstly de-
tected the expression of HIF-2α and E-cadherin pro-
teins in 70 pancreatic cancer tissues and matching
adjacent non-tumor tissues by IHC staining. In our
immunostaining results, the location of HIF-2α pro-
tein was observed mainly in the cytoplasm and nu-
cleus, while the staining for E-cadherin was confined
to the cytomembrane (Fig. 1). HIF-2α protein was
expressed positively in 67.1 % (47/70) of pancreatic
cancer tissues and 11.4 % (8/70) of adjacent non-
tumor pancreatic tissues. There was a significant dif-
ference in the positive rate of HIF-2α protein between
the pancreatic cancer tissues group and non-tumor
tissues group (χ2 = 45.549, P < 0.05). Whereas, the ex-
pression of E-cadherin protein was significantly lower
in pancreatic tumor tissues (21/70) than in non-
tumor tissues (43/70), showing a significant difference
(χ2 = 13.931, P < 0.05).
We further investigated whether expression of HIF-2α
and E-cadherin was correlated with clinicopathological
characteristics of pancreatic cancer patients. As shown
in Table 1, HIF-2α expression was correlated with tumor
differentiation (χ2 = 6.921, P = 0.026), clinical stage (χ2 =
6.460, P = 0.017) and lymph node metastasis (χ2 = 5.250,
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P = 0.040). However, the staining for HIF-2α had no sig-
nificant association with gender, age, tumor location,
tumor size (P > 0.05). These results indicated that the
overexpression of HIF-2α might be correlated with poor
differentiation and advanced clinical stage of pancreatic
cancer. On the other hand, the staining for E-cadherin
was obviously only associated with lymph node metasta-
sis (χ2 = 8.221, P = 0.006). In Table 2, we found that ex-
pression of HIF-2α was negatively related to E-cadherin
in pancreatic cancer tissues (r = −0.394, P < 0.05).
Fig. 1 Expression of HIF-2α and E-cadherin in pancreatic cancer and adjacent non-tumor tissues. Original magnification × 100 or 400. Images are
representative of three independent experiments
Table 1 Expression of HIF-2α and E-cadherin, and the relation with the clinicopathologic features in pancreatic carcinoma
Variables HIF-2α E-cadherin
No. Positive Negative P-value Positive Negative P-value
Gender 0.306 0.424
Male 42 26 16 13 29
Female 28 21 7 6 22
Age (years) 1.000 0.107
≤ 65 41 28 13 8 33
> 65 29 19 10 11 18
Tumor location 0.569 0.226
Head 52 36 16 12 40
Body and tail 18 11 7 7 11
Tumor size (cm) 0.122 0.414
≤ 2 27 15 12 9 18
> 2 43 32 11 10 33
Differentiation 0.026 0.784
Well 8 3 5 3 5
Moderate 17 9 8 5 12
Poor 45 35 10 11 34
Clinical stage 0.017 0.579
I 25 12 13 8 17
II 45 35 10 11 34
Lymph node Metastasis
Yes 38 30 8 0.040 5 33 0.006
No 32 17 15 14 18
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UP-regulation and down-regulation of HIF-2α in pancreatic
cell lines
We detected and compared the expression level of
HIF-2α protein in five pancreatic cell lines, including
BxPc-3, CaPan-2, Patu8988, SW1990 and AsPC-1 by
Western Blot. From the results, we found that AsPC-
1 cells had a highest expression of HIF-2α in contrast
with the SW1990 cells, which expressed a low level
(Fig. 2a). To investigate whether HIF-2α contributes
to EMT, we first established AsPC-1 cells with silen-
cing of HIF-2α expression by siRNA, on the contrary,
SW1990 cells were transfected with HIF-2α cDNA to
up-regulate HIF-2α expression. As shown in Fig. 2b,
the expression of HIF-2α was significant up-regulated
in SW1990 cells following transfection with OE-HIF-
2α cells (P < 0.05), while the expression of HIF-2α
was significant down-regulated in AsPC-1 cells fol-
lowing transfection with si-HIF-2α cells (P < 0.05).
HIF-2α promotes cell migration, invasion in vitro
EMT is considered to be associated with cell migration
and invasion among tumor cells. We investigated the
cell migration and invasion ability via the wound healing
assay and transwell systems after performing HIF-2α ec-
topic transfection or HIF-2α knockdown, respectively. In
the transwell assay, about 3-fold a decrease in cells
passed Matrigel was observed in si-HIF-2α group com-
pared with si-Scramble groups (P < 0.01). We also found
a 5-fold increase in OE-HIF-2α group than Vector group
(P < 0.01) (Fig. 3a). Similar results showed in the wound
healing assay that si-HIF-2α cells conducted relatively
slower migration towards the wound space compared
with si-Scramble cells (P < 0.05) (Fig. 3b). These results
showed that HIF-2α played an important role in the pro-
gress of pancreatic cancer cells in vitro, and perhaps par-
ticipated in the EMT process through increasing the
ability of cell migration and invasion.
Effect of HIF-2α on the EMT related proteins
To understand the interval molecular mechanism of
HIF-2α involving in EMT, we investigated the expression
levels of EMT related proteins after regulating HIF-2α
by Western Blot. As shown in Fig. 4, a significantly in-
creased expression of E-cadherin was observed in si-
HIF-2α AsPC-1 cells compared with si-Scramble cells
(P < 0.05). In SW1990 cells, after up-regulating HIF-2α
Table 2 The relationship of HIF-2α and E-cadherin in pancreatic
cancer tissues
Variables HIF-2α r P-value
Positive Negative
E-cadherin
Positive 7 12 −0.394 0.002
Negative 40 11
Fig. 2 Expression of HIF-2α in pancreatic cell lines and regulating HIF-2α in AsPC-1 and SW1990 cells. a Relative expression of HIF-2α protein in
pancreatic cancer cell lines (BXPC-3, CaPan-2, PaTu8988, SW1990 and AsPC-1) was measured by Western blot. b Expression of ectopic expression
and knockdown of HIF-2α in SW1990 or AsPC-1 cells by Western blot. Images are representative of three independent experiments. *P < 0.05
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through transfecting HIF-2α cDNA, the results of which
showed a decrease of the expression of E-cadherin
(P < 0.05). It had little effect on β-catenin when reg-
ulated HIF-2α in these two cell lines (P > 0.05). To
further determine whether HIF-2α affected MMPs
expression in pancreatic cancer cells, we analyzed
the expression of MMPs in both AsPC-1 and
SW1990 cells. After down-regulating HIF-2α, expres-
sion level of MMP2 and MMP9 was reduced in si-
HIF-2α group compared with si-Scramble groups in
AsPC-1 cells (P < 0.05, respectively). Similarly, find-
ings were shown in SW1990 cells, OE-HIF-2α group
expressed higher MMP2 and MMP9 level than the
negative Vector group (P < 0.05, respectively). These
Fig. 3 HIF-2α promoted cell migration and invasion. a Cell invasion was detected by the Transwell assay. Representative images of cell invasion
captured under an inverted microscope (original magnifiation, ×200). The data represent the means ± SD of 5 experiments. **P < 0.01. b Cell
migration was detected by the wound scrape assay. Representative images of cell migration in the wound scrape model at 0, 24 h and 48 h are
shown; original magnifiation, ×100. The data represent the means ± SD of three experiments. *P < 0.05
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results demonstrated that HIF-2α regulated the ex-
pression of E-cadherin and MMPs, which were crit-
ical to EMT.
HIF-2α promotes EMT through Twist binding the
promoter region of E-cadherin
Twist is identified as a main transcription factor asso-
ciated with EMT process [15]. We firstly investigated
whether HIF-2α affected the expression of Twist1 and
Twist2. As shown in Fig. 5a, silencing of HIF-2α in
cells could decrease the level of Twist1 and Twist2
proteins (P < 0.05, respectively), and similar results
were shown in up-regulating HIF-2α (P < 0.05, re-
spectively). It suggested that HIF-2α could regulate
the expression of Twist1 and Twist2. In the process
of EMT, E-cadherin plays a key role as a regulator in
intercellular adhesion. The promoter region of the E-
cadherin gene was analyzed by Patch software to
identify potential binding sites for transcription fac-
tors. Two potential Twist protein binding sites, separ-
ately designated P1 (−295 bp) and P2 (−714 bp) were
identified by the Patch database of transcription factor
binding sites (Table 3). To test whether Twist1 and
Twist2 could bind to the promoter region of E-
cadherin, we performed a ChIP assay on AsPC-1
cells, which was overexpression of Twist1 and Twist2.
The Twist2 antibody specifically immunoprecipitated
a Twist2-DNA complex in the correlated region of
the E-cadherin promoter, and the binding of Twist2
and P2 regions was demonstrated by PCR performed
with relevant specific primers (Fig. 5b). But the re-
sults showed Twist2 had no positive binding capacity
to the P1 region site of E-cadherin. However, there
were no obviously results to demonstrate the Twist1
had binding capacity to the transcription region of E-
cadherin in both P1 and P2 binding sites through the
Fig. 4 Effect of HIF-2α on expression of EMT-related proteins. E-cadherin, β-catenin, MMP2 and MMP9 was examined in AsPC-1 cells silencing of
HIF-2α expression and SW1990 cells transfected with HIF-2α cDNA by Western blot. Images are representative of three independent
experiments. *P < 0.05
Fig. 5 HIF-2α promotes EMT through Twist binding to the promoter region of E-cadherin. a Twist1 and Twist2 expressions in response to up-regulation or
silencing of HIF-2α in pancreatic cancer cells were detected by Western blot. b ChIP of Twist1 and Twist2 interactions with the E-cadherin promoter. Bands
are PCR products targeting P1 and P2 of the E-cadherin promoter. The specific anti-Twist1, anti-Twist2 or control normal mouse IgG was used for
immunoprecipitations, whereas genomic DNA was used as the input control
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ChIP assay. These results indicated that Twist2 was
directly bound to E-cadherin promoter through P2 re-
gion, but not P1 region.
The relationship of Twist1/2 and E-cadherin in clinical
tissues
To obtain clinical evidence of the correction between
Twist1, Twist2 and E-cadherin, we tested the expression
of Twist1 and Twist2 in the above-mentioned 70 pan-
creatic cancer tissues by IHC staining. As shown in
Fig. 6, the results showed that Twist1 and Twist2 ex-
pressions were located in the cytoplasm of pancreatic
cancer cells. The difference in Twist1 expression was no
statistically significant between E-cadherin positive ex-
pression and negative expression (P > 0.05). While, the
E-cadherin negative group expressed a higher level of
Tiwst2 compared with the positive group (P < 0.05). In
Table 4, our results showed that Twist2 and E-cadherin
expression had an obviously negative correlation in pan-
creatic cancer tissues (r = − 0.417, P < 0.05), however, it
had no obvious correlation between Twist1 and E-
cadherin (r = − 0.114, P > 0.05).
Discussion
As a most deadly gastrointestinal carcinoma, pancreatic
cancer leads to a hypoxic environment because of its
rapidly growth and plentiful oxygen demand. HIF-2α is
confined to the cell nucleus and expresses only under
the condition of hypoxic stimulation. A better under-
standing the molecular mechanism of HIF-2α may be
benefit to explore new promising therapeutic strategies
for the treatment of pancreatic cancer. In our present
study, we examined the expression of HIF-2α in 70
matched clinical pancreatic cancer tissues. The results
showed that HIF-2α was overexpressed in pancreatic
cancer tissues, and HIF-2α expression was correlated
with poor differentiation, advanced clinical stage and
lymph node metastasis. It suggested that overexpression
of HIF-2α was frequently detected in patients with poor
pathological characteristics.
Hypoxia is a common phenomenon in many tumors,
especially in most types of human tumors, including
breast, colon, ovarian, pancreatic, prostate, renal and he-
patocellular cancers [7, 16]. HIF-1α and HIF-2α are key
transcription factors in tumor development and only ac-
cumulate in hypoxic tumors [17, 18]. HIF-2α, as an im-
portant hypoxia-related factor, regulates the adaptive
response to decreased O2 availability at the cellular and
organismal level [7]. Previous report shows that HIF-2α
is involved in the invasion and metastasis of gastric can-
cer cells under hypoxia [19]. In our study, depletion of
HIF-2α expression obviously inhibited the migration and
Table 3 Predict potential Twist binding sites in the promotor
region of E-cadherin gene (Patch software)
Twist binding site Position Sequence
P1 −310 bp to -291 bp (+) gtgtCAAATGcttagcacag
P2 −729 bp to -710 bp (−) gaaaCATTTGtcatttaatt
Fig. 6 Representative immunohistochemical staining of Twist1 and Twist2 in the two groups of pancreatic cancer tissues with E-cadherin positive
or E-cadherin negative expression. Original magnification × 200. Images are representative of three independent experiments
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invasion of AsPC-1 cells, and the opposite effect was
shown in upregulation of HIF-2α in SW1990 cells. Thus,
it was plausible to consider that HIF-2α promoted cell
invasion and migration in pancreatic cancer.
EMT plays an important role in the development of
tissues during embryogenesis, however, similar phenom-
ena was found in pathological processes, including can-
cer [20]. As the first stage of invasion and metastasis,
EMT was reported involving in the development of
many solid cancers, including gastric cancer [21], colon
cancer [22] and breast cancer [23]. Metastasis is a com-
plex process, and it represents products of a multistep
cell-biological process termed the invasion-metastasis
cascade, which involves spread of cancer cells to distant
organs and adaptation to their microenvironments [24].
The mechanism between tumor cell plasticity and the
EMT process may be the same and may thus have a
similar relevance [25].
Several pivotal proteins are necessary for the occur-
rence and progress of EMT in various cancers, among
which E-cadherin is the most critical regulator. E-
cadherin is a typical epithelial marker, and loss of E-
cadherin is an important characteristic of occurrence of
EMT [26], the reason for this program is that loss of E-
cadherin expression confuses cell polarity and also de-
creases the stability in epithelial cells. The expression of
E-cadherin is regularly lost or decreased in advanced tu-
mors and it is possibly linked to a higher incidence of
metastasis and recurrence [27]. Our present findings re-
vealed that pancreatic cancer expressed obviously lower
E-cadherin than matched adjacent non-tumor tissues
and E-cadherin expression was negatively correlated
with lymph node metastasis. It indicates that decreased
E-cadherin level contributes to reduce the combining
capacity and stability among pancreatic cancer cells,
thus, it provides convenience for cells to metastasis. In
our study, HIF-2α may induce EMT via decreasing the
expression of E-cadherin. Meanwhile our study showed
that overexpression of HIF-2α enhanced the expression
of MMP2 and MMP9, which are closely related to tumor
metastasis, are also significant to EMT [28]. This result
further confirmed that HIF-2α promoted EMT in pan-
creatic cancer. It seems reasonable that HIF-2α takes
part in the development of pancreatic cancer through
EMT to promote the invasion and metastasis of pancre-
atic cancer.
Twist1 and Twist2, as the main EMT-mediated
process regulators, express high structural homology,
and gene deletion tests have proved that two proteins
share some similar effects and functions, such as their
role in tumor progression and metastasis and their regu-
lation of hematological malignancies [29, 30]. Twist can
reduce the expression of E-cadherin through binding to
the two bipartite E-box motifs within E-cadherin pro-
moter and inhibiting its transcription [31], suggesting
that Twist contributes to metastasis by promoting EMT.
However, the mechanism of HIF-2α, Twist1/2 and E-
cadherin is still poorly understood. In the present study,
we found that Twist1, Twist2 and E-cadherin were regu-
lated by HIF-2α in pancreatic cancer cells. Our further
ChIP assay suggested that only Twist2 could bind to the
promoter of E-cadherin in -714 bp region site, but there
was no positive binding capacity in -295 bp promoter re-
gion site of E-cadherin. Twist1 had no similar effect on
above-mentioned promoter region site of E-cadherin.
Clinical tissues IHC staining showed that Twist2 and E-
cadherin expression had an obviously negative correl-
ation in pancreatic cancer tissues, however, it had no
obvious correlation between Twist1 and E-cadherin.
While Sun et.al indicated that Twist1 contributed to
EMT process through down-regulation of E-cadherin
expression in hepatocellular carcinoma (HCC) [25].
Those studies along with our findings indicate that
the function of Twist1/2 and E-cadherin in cancer
progression depends on different tumor types. The
accurate mechanism of how Twist1/2 affects the
promoter capacity of E-cadherin is remained to be
characterized.
Conclusion
In conclusion, our study demonstrated that HIF-2α was
overexpressed in pancreatic cancer and associated with
poor pathological characteristics. Our findings indicate that
HIF-2α promotes EMT in vitro, at least in part by regulat-
ing Twist2/E-cadherin pathway. And whether blockage of
HIF-2α may prove to be an effective therapeutic strategy in
pancreatic cancer deserved further exploration.
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